US to authorise Pfizer Covid-19 vaccine for ages 12-15 next week, reports NYT

The U.S. Food and Drug Administration is preparing to authorize Pfizer Inc and German partner BioNTech SE's COVID-19 vaccine for adolescents aged between 12 and 15 years by early next week, the New York Times reported on Monday, citing federal officials familiar with the agency's plans.

source https://www.france24.com/en/americas/20210503-us-to-authorise-pfizer-covid-19-vaccine-for-ages-12-15-next-week-reports-nyt